Medicare Part D Pharmaceutical Plans
Search documents
What the Options Market Tells Us About Centene - Centene (NYSE:CNC)
Benzingaยท 2025-09-26 17:01
Core Insights - Whales have shown a bullish stance on Centene, with 46% of trades being bullish and 46% bearish, indicating a balanced sentiment among large investors [1] - The total amount for put trades is $439,754, while call trades amount to $2,196,457, suggesting a stronger interest in calls [1] Options Activity - Over the last three months, whales have targeted a price range for Centene between $25.0 and $55.0 [2] - In the last 30 days, the volume and open interest for Centene's options have been analyzed, providing insights into liquidity and investor interest [3][4] Noteworthy Trades - Significant trades include bullish call options with a total trade price of $303.3K at a strike price of $25.00, and bearish call options with a total trade price of $261.1K at the same strike price [8] - Other notable trades include a bullish put option with a total trade price of $159.9K at a strike price of $37.00 [8] Company Overview - Centene is a managed care organization focusing on government-sponsored healthcare plans, serving 22 million medical members as of December 2024, with a majority in Medicaid [9][10] - The company also provides Medicare Part D pharmaceutical plans and has a military contract [10] Market Analysis - Analysts have provided ratings for Centene, with an average target price of $35.75, and individual targets ranging from $33 to $39 from various analysts [11][12] - The current trading volume for Centene is 5,833,297, with the stock price up by 2.31% to $35.19, indicating potential overbought conditions [14]